Adipose-derived stromal stem cells (ASCs) as a new regenerative immediate therapy combating coronavirus (COVID-19)-induced pneumonia
- PMID: 32329380
- PMCID: PMC7196919
- DOI: 10.1080/14712598.2020.1761322
Adipose-derived stromal stem cells (ASCs) as a new regenerative immediate therapy combating coronavirus (COVID-19)-induced pneumonia
Keywords: Mesenchymal stem cells coronavirus; adipose-derived stem cells coronavirus; cellular therapy COVID-19; mesenchymal stem cells COVID-19; stem cell therapy COVID-19.
Figures
Comment on
-
Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia.Aging Dis. 2020 Mar 9;11(2):216-228. doi: 10.14336/AD.2020.0228. eCollection 2020 Apr. Aging Dis. 2020. PMID: 32257537 Free PMC article.
References
-
- Munster VJ, Koopmans M, van Doremalen N, et al. A novel coronavirus emerging in China - key questions for impact assessment. N Engl J Med. 2020;382(8):692–694. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources